Of note, APOE ε2 is not only a protective gene but might also increase the risk of certain cerebrovascular diseases and neurological disorders (Li et al., 2020), which could also contribute to the reduced frequency of APOE ε2 carriers among ≥65 years old individuals in our study population. The gene discussed is APOE; the disease is cerebrovascular disorder.